US Broker Ratings

Marti Technologies, Inc. (MRT): Investor Outlook Reveals a Potential 112% Upside

Investors looking for high-growth potential in the dynamic world of urban mobility should take a closer look at Marti Technologies, Inc. (MRT). This Turkey-based technology company is making waves with..

Fulcrum Therapeutics, Inc. (FULC) Investor Outlook: Exploring a Potential 60% Upside in Biotech Innovation

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is making waves in the biotechnology sector with its focus on developing small molecules to address genetically defined diseases. With a current market capitalization of..

Grab Holdings Limited (GRAB): Investor Outlook and Growth Potential with a 11.74% Upside

Grab Holdings Limited (NASDAQ: GRAB) is an intriguing player in the technology sector, particularly within the Software – Application industry. As a pioneering force in Southeast Asia, Grab has carved..

Mereo BioPharma Group plc (MREO): Analyst Consensus Points to Remarkable 310% Upside Potential

Mereo BioPharma Group plc (NASDAQ: MREO), a dynamic player in the biotechnology sector, is capturing investor attention with its compelling growth narrative and significant upside potential. With a market capitalization..

Alumis Inc. (ALMS) Stock Analysis: Unveiling a 398% Potential Upside in Biotech

In the ever-evolving landscape of biotechnology, Alumis Inc. (NASDAQ: ALMS) stands out as a promising contender with a striking potential upside of 398.26%. This clinical-stage biopharmaceutical company, headquartered in South..

Quantum-Si Incorporated (QSI) Investor Outlook: Analyzing a 74.90% Potential Upside in the Healthcare Sector

Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector with its cutting-edge advancements in Next Generation Protein Sequencing (NGPS). As a key player in the medical devices industry,..

TotalEnergies SE (TTE) Stock Analysis: Exploring a 15% Upside Potential

TotalEnergies SE (TTE), a major player in the global energy sector, continues to capture the attention of investors with its diverse portfolio and strategic positioning in the oil and gas..

Canopy Growth Corporation (CGC) Stock Analysis: Is a 259% Upside Within Reach?

Investors with an eye on the healthcare sector, particularly the burgeoning cannabis industry, may find Canopy Growth Corporation (NASDAQ: CGC) a company worth watching. Despite facing significant challenges, recent analyst..

Varex Imaging Corporation (VREX) Investor Outlook: Unpacking a 122.82% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX), a pivotal player in the healthcare sector, primarily focuses on the development and sale of X-ray imaging components. With a market capitalization of $309.27 million,..

Health Catalyst, Inc (HCAT) Stock Analysis: Exploring an 87.20% Potential Upside for Investors

Health Catalyst, Inc (NASDAQ: HCAT), a key player in the health information services sector, provides innovative data and analytics technology solutions for healthcare organizations across the United States. With a..

Fair Isaac Corporation (FICO) Stock Analysis: Exploring 35% Potential Upside for Tech-Savvy Investors

Fair Isaac Corporation, trading under the ticker FICO, stands as a formidable player in the technology sector, particularly within the software application industry. With a market capitalization of $37.19 billion,..

Phathom Pharmaceuticals (PHAT) Investor Outlook: Analyzing a Potential 128% Upside in Biotech

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) presents an intriguing opportunity for investors within the dynamic biotechnology sector. With a market capitalization of $608.08 million and a compelling upside potential of 128.19%,..

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a Potential 226% Upside in the Biotech Sector

Aura Biosciences, Inc. (NASDAQ: AURA) is capturing the attention of investors with its promising potential in the biotechnology sector. As a clinical-stage biotech company, Aura is pioneering precision therapies aimed..

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a Significant 90% Potential Upside

Viemed Healthcare, Inc. (NASDAQ: VMD), a prominent player in the medical devices sector, is capturing the attention of investors with a significant potential upside of 90.13%. With a market capitalization..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Exploring a Potential 319.67% Upside

Compass Therapeutics, Inc. (NASDAQ: CMPX), a burgeoning player in the biotechnology sector, is gaining substantial attention from investors due to its promising pipeline of antibody-based therapeutics and a significant potential..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 106% Potential Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO) stands at an intriguing juncture for investors, with analysts projecting a significant potential upside of 106.61%. As a key player in the healthcare sector, specializing..

Outset Medical, Inc. (OM) Stock Analysis: Unveiling a 44.97% Potential Upside in the Medical Devices Sector

Outset Medical, Inc. (NASDAQ: OM), a dynamic player in the healthcare sector specializing in medical devices, is garnering attention with its innovative approach to hemodialysis. The company’s flagship product, the..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Biotechnology Firm’s Potential 208% Upside Grabs Investor Attention

Entrada Therapeutics, Inc. (NASDAQ: TRDA) is a clinical-stage biotechnology company that has been making waves in the healthcare sector with its innovative approach to treating neuromuscular diseases. Headquartered in Boston,..

Exxon Mobil Corporation (XOM) Investor Outlook: Exploring the 10.66% Upside Potential

Exxon Mobil Corporation (NYSE: XOM) remains a titan in the energy sector, serving as a beacon for investors seeking a sturdy foothold in the oil and gas integrated industry. With..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Potential 431.97% Upside Amid Biotech Innovation

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a burgeoning player in the biotechnology sector, is drawing investor interest with its promising pipeline of mRNA-based therapeutics and vaccines. Despite a challenging fiscal..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds